Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-14

Clinical Trial Update: Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

View source ↗

Summary

A completed clinical trial update on persistence with Denosumab (Prolia) in postmenopausal women with osteoporosis, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prolia (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis, Age-Related | Status: COMPLETED | Results posted: 2016-12-14